Skip to content

All Press Releases

PILA PHARMA AB, announces API manufacturing milestone achieved and changes to organisation

Malmö, Sweden, 04 February 2022 Download the press release as PDF here PILA PHARMA AB (PILA) today announces their first API manufacturing milestone has been successfully achieved.  The manufacture of new XEN-D0501 API for the planned preclinical safety studies was, as announced 6 months ago, outsourced to Almac Group. The task to manufacture a critical API “starting material” was managed by…

Read more

PILA PHARMA AB, announces ink of agreement with pre-clinical service provider ERBC

Malmö, Sweden, 26 November 2021 Download the press release as PDF here PILA PHARMA AB (publ) announces that an agreement has been signed with the company ERBC, regarding the conduct of PILA PHARMA´s upcoming preclinical safety assessment studies. ERBC is a certified pre-clinical service provider, based in France and Italy. PILA PHARMA is, as previously announced, preparing a clinical phase…

Read more

PILA PHARMA AB skriver avtal med den prekliniska tjänstleveranören ERBC

Malmö, 26 november, 2021 Läs pressmeddelandet som PDF här PILA PHARMA AB (publ) meddelar att ett avtal har tecknats med företaget ERBC avseende genomförandet av PILA PHARMA:s kommande icke-kliniska toxikologiska studier. ERBC är en certifierad pre-klinisk tjänsteleverantör med säte i Frankrike och Italien. PILA PHARMA förbereder, som tidigare meddelats, en klinisk fas 2b-studie av läkemedelskandidaten XEN-D0501 mot diabetes typ 2.…

Read more

Contact us

Subscription for press releases
Back To Top